Universal screening isn't cost-effective in detecting celiac disease

06/2/2013 | Family Practice News

Universal serologic screening for celiac disease among 12-year-olds was more costly and yielded no gains in long-term quality of life in relation with bone health compared with the standard selective screening, a study in the journal Clinical Gastroenterology and Hepatology showed. Researchers also said that universal serological screening can lead to negative outcomes from unneeded endoscopic evaluations of healthy people if screening is falsely positive.

View Full Article in:

Family Practice News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA